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Abstract
Background: Phosphatidylcholine (PC), the major source of dietary choline, has been demonstrated to improve the
capability of learning and memory in rodent and the amelioration of long-chain n-3 polyunsaturated fatty acids (PUFA)
on anti-aging and anti-oxidation is widely known as well. In this study, three kinds of PC were chose to demonstrate
the role of different fatty acids composition on glycerol backbone in improving the brain function of mice induced by
scopolamine which was used to impair cholinergic system and cause oxidative stress.
Methods: Male BALB/c mice were randomly divided into 5 groups: model (M) group, control (Con) group,
egg yolk lecithin (EL) group, squid PC (SQ-PC) group and sea cucumber PC (SC-PC) group. The intraperitoneal
injection of scopolamine hydrobromide (5 mg/kg) was carried out on the 8th of group feeding and sustained
daily until the end of test. Morris water maze test was used to evaluate the improvement of cognitive
decline and the activity of acetylcholinesterase (AchE), superoxide dismutase (SOD) and monoamine oxidase
(MAO) and malondialdehyde (MDA) content in brain were measured to assess the physiological changes.
Results: In behavior test, the latency of PC groups was significantly reduced, while number of crossing the platform
and time in target quadrant were increased in comparison with M group and the improvements of SQ-PC and SC-PC
were better than that of EL (P < 0.05). Similar trend was observed in physiological changes. The AchE activity was
effectively decreased and the SOD activity increased in hippocampus, cortex and white matter when comparing PC
groups with M group. SQ-PC, SC-PC and EL respectively showed 22.82, 28.80 and 11.81 % decrease in MDA level in
brain compared with M group. The MAO activity in white matter of SQ-PC, SC-PC and EL group separately depressed
33.05, 33.64 and 19.73 % in comparison with M group. No significance between SQ-PC and SC-PC was found in these
indicators except the SOD activity in hippocampus and white matter. SQ-PC group had a higher SOD activity in
hippocampus (103.68U/mg · prot.) and lower in white matter (120.57 U/mg · prot.) than SC-PC group (95.53 U/mg · prot.
in hippocampus, 134.49 U/mg · prot. in white matter). PC rich in n-3 PUFA acted more ameliorative effects than that
barely contained on the indicators above.
Conclusions: Different fatty acids composition of PC all could diminish the cognitive decline and biological damage
and protect the brain. EPA and DHA partly enhaced to the advantageous effects.
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Background
Alzheimer’s disease (AD) is characterized by the pro-
gressive decline in memory and cognitive function [1]. It
is also one of the most important forms of dementia and
has become into an enormous financial burden on soci-
ety with the rapid growth of elderly population in the
worldwide [2]. The most disappointing and hopeless
thing is that we have not found an effective treatment to
cure or just suspend the disease. AD causes substantial
changes in brain including synaptic and neuronal loss,
Aβ deposition, hyperphosphorylation of Tau and neuro-
brillary tangles [3, 4]. There are many hypothesis re-
ported about the pathogenesis of AD, in which oxidative
stress and cholinergic damage are highly acceptable
[5, 6]. It is a critical element that the level of brain
acetylcholine (Ach) was persistently decreasing in the
process of AD. The drugs that increase the content of
the neurotransmitter Ach by inhibiting acetylcholine es-
terase for treating the AD patients are approved by U.S.
Food and Drug Administration (FDA) currently [7].
However, most of these drugs should be used for a long-
term condition on account of their transiently curative
effect, which resulted in a series of adverse effects and
suffering such as headache, insomnia and emesis [8].
The developments of preventing and curing AD through
diet therapy are pregnant and necessary. It is a very ap-
propriate way to enhance nutraceuticals in daily diet. It
provides plenty of medical or health benefits such as im-
proving the metabolism of glucose and lipid [9], chan-
ging the lipid composition of brain [10], antioxidation
and anti-aging [11]. Escalating reports give us a common
sense that diet supplementation with phospholipids (espe-
cially functional type) plays a positive role in protecting
the nervous system and improving memory [12–14].
Meanwhile, the effect of long-chain n-3 polyunsaturated
fatty acids (PUFA) of aquatic product on anti-oxidative
damage is generally recognized [15]. Docosahexaenoic
acid (DHA) and eicosapentaenoic acid (EPA), the main
PUFA in fish oil, make the greatest contribution to the
biological activities such as promoting the growth of cere-
bral cells and improving memory [16]. DHA is the main
composition of member lipid in the nerve cells and the
priority resource of fatty acid in brain cells. As an effective
anti-inflammatory bioactivator, EPA has been increasingly
reported to own the capability of preventing the inflam-
mation in neurodegenerative disease [17, 18]. It is widely
acknowledged that egg yolk lecithin has a good effect on
mopping up free radicals and anti-aging [19]. Meanwhile
phosphatidylcholine (PC) is the major source of dietary
choline and it has been demonstrated that intake of PC can
improve the capability of learning and memory in rats to
some extent [20]. As the main component of lipid bilayer
structure of cell membrane, PC acts a vital part in mem-
brane fusion and transport [21], endocytosis and the cata-
lytic activity of enzymes [22] and the function of lowering
blood lipid and cholesterol levels, preventing cardiovascular
disease and inhibiting obesity have been illuminated as well
[10]. However, it is rarely illustrated whether the difference
of fatty acids composition on glycerol backbone of PC mol-
ecule has influence on the improvements.
As a muscarinic anti-cholinergic drug, Scopolamine
(SCO) can block the combination of neural acetyl choline
(Ach) and its receptor, disrupt the transmission of
cholinergic signal and lead to clinical manifestations of de-
mentia [7]. Simultaneously, it is able to decrease the anti-
oxidative enzyme activity and increase the level of radical
[23]. Therefore, it becomes a widely used drug to induce
dementia models by impairing short-term learning and
memory [24]. SCO induces cognitive impairment with an
attenuation of cholinergic neurotransmission and increase
of oxidative stress [25]. Thus, nutraceuticals which can
significantly improve cholinergic system and/or oxidative
stress might reverse this damage. In this study, we chose
three kinds of PC: egg yolk lecithin (coventional type PC),
sea cucumber PC (rich in EPA) and squid PC (rich in
DHA) to investigate the effect of different fatty acids com-
position of PC on the brain function of dementia BALB/c
mice induced by intraperitoneal injection of scopolamine
hydrobromide in 2-week short term test.
Result
Morris water maze test
As the intraperitoneal injection of Scopolamine hydro-
bromide was daily kept during the entire test, the time
used to find the platform was becoming significant lon-
ger in M group than that in Con group during the 6-
day’s training (Fig. 1). Compared to the Model group,
the latency of SQ-PC group and SC-PC group mice was
continuous and notablely decreased and the significance
of EL group emerged on the 4th (P < 0.05), 5th (P < 0.01)
and 6th (P < 0.01) day of the test. In the meantime, we
found a significance arose between EL group and SC-PC
group as well as that between EL group and SQ-PC
group and was persistent until the end of the test. None-
theless, the difference between SQ-PC group and SC-PC
group was not distinct (Fig. 1a).
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Fig. 1 Effects of different fatty acids composition of PC on behavior test. Comparison of latency to find the platform (a), total distance traveled
(b), number of crossing the platform (c) and time in the target quadrant (d) among mice with experimental diets. Results are expressed as mean
± SEM; n = 8 mice per group. ##P < 0.01, significant difference compared with Con group, *P < 0.05, **P < 0.01, significant difference compared
with M group, determined by student’s t test. Different letters represent significant difference at P < 0.05 among PC groups determined by
ANOVA (Tukey’s test)
Fig. 2 Effects of different fatty acids composition of PC on AchE activity. Comparison of AchE activity in hippocampus (a), cortex (b) and white
matter (c) among mice with experimental diets. Results are expressed as mean ± SEM; n = 8 mice per group. ##P < 0.01, significant difference
compared with Con group, *P < 0.05, **P < 0.01, significant difference compared with M group, determined by student’s t test. Different letters
represent significant difference at P < 0.05 among PC groups determined by ANOVA (Tukey’s test)
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No significance was found in total distance traveled of
all groups mice, however the number of crossing the plat-
form and the time in target quadrant (quadrant I) had a
remarkable difference after the platform was removed
from the pool (Fig. 1b). Numbers of M (P < 0.01) group
mice crossing the platform was significantly less than that
of the Con group and SQ-PC group (P < 0.01) and SC-PC
(P < 0.01) group mice showed a great improvements and
EL group (P < 0.05) also achieved partially better when
compared with M group. The result of the contrast among
three PC groups showed the ameliorative effect of SQ-PC
group and SC-PC group was better than EL group
(Fig. 1c). According to the comparison between Con
group and M group mice, time in the quadrant I notly de-
creased from 38.39 s to 10.89 s.SQ-PC group and SC-PC
group mice remained in quadrant I for respectively
32.24 s and 29.40s which meant obvious increase in con-
trast to M group, meanwhile EL group mice improved the
time to 24.30s and also showed significance. In consistent
with the performance of number of crossing the platform,
SQ-PC group and SC-PC group had also achieved a better
result than EL group in the time in quadrant I (Fig. 1d).
AchE activity
Since acetylcholin esterase was one of the most relevant
enzyme to acetyl choline (Ach), which was the important
neurotransmitter in central cholinergic system and
played a vital role in learning and memory, we investi-
gated the AchE activity in hippocampus (Fig. 2a), cortex
(Fig. 2b) and white matter (Fig. 2c). Generally, SCO-
administration severely increased the AchE activity of M
group (P < 0.01) in the areas of mice brain when com-
pared to Con group. Contrasting the PC groups with M
group, we could conclude that the PC groups all de-
creased the AchE activity effectively and SQ-PC group
(P < 0.01) and SC-PC group (P < 0.01) showed more sig-
nificant than EL group (P < 0.05). Similar trend of differ-
ence was observed in hippocampus, cortex and white
matter with the comparison among the PC groups, that
SQ-PC group and SC-PC group had a remarkable effect
on decreasing the AchE activity by contrast with EL
group and no significance was presented when compar-
ing SQ-PC group and SC-PC group.
Oxidative stress in brain
Superoxide dismutase (SOD) activity and malondialde-
hyde (MDA) level, two representative oxidative stress in-
dicators, were measured. The results showed that the
administration of Scopolamine hydrobromide signifi-
cantly increased the oxidative stress in M group mice as
the SOD activity in cortex (P < 0.01), hippocampus (P <
0.01) and white matter (P < 0.01) of M group mice were
markedly lower and the MDA level in brain (P < 0.01)
was higher in comparison with Con group (Fig. 3).
Fig. 3 Effects of different fatty acids composition of PC on oxidative stress. Comparison of SOD activity in hippocampus (a), cortex (b) and white
matter (c) among mice with experimental diets. d Comparison of MDA level in brain among mice with experimental diets. Results are expressed
as mean ± SEM; n = 8 mice per group. ##P < 0.01, significant difference compared with Con group, *P < 0.05, **P < 0.01, significant difference
compared with M group, determined by student’s t test. Different letters represent significant difference at P < 0.05 among PC groups determined
by ANOVA (Tukey’s test)
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Compared to M group, the three kinds of PC effectively
improved the SOD activity in hippocampus (Fig. 3a),
cortex (Fig. 3b) and white matter (Fig. 3c).
Similar results were presented in the comparison of
the effect on decreasing the MDA level (Fig. 3d) in mice
brain between the PC groups and M group. Further-
more, SQ-PC group and SC-PC group showed more ef-
fective results than EL group while comparing with the
PC groups. The difference between SQ-PC group and
SC-PC group was not as same as that in the test above.
SQ-PC group mice had a higher SOD activity in hippo-
campus and lower in white matter than SC-PC group.
However, no significance was showed in SOD activity in
cortex and MDA level in brain between the two groups.
MAO activity
The result of MAO activity in white matter was shown in
Fig. 4. M group displayed a significant increase of MAO
activity in white matter when compared with Con group.
EL group, SQ-PC group and SC-PC group decreased the
MAO activity by 19.7 % (P < 0.05), 34.0 % (P < 0.01) and
34.6 % (P < 0.01) respectively in contrast to M group. No
significance was found between SQ-PC group and SC-PC
group and each of the two groups performed better than
EL group in improving the MAO activity in white matter
with the comparison between the PC groups.
Discussion
Recently, increasing interest in improving the clinical
symptoms of AD patients and enhancing their self-care
ability of daily living has generated [26, 27]. It is an appro-
priate strategy to add some effective compounds derived
from plants and animals into the diets so that this fragile
population will be able to keep away from the painful side
effects which most of drugs have in common. It has been
thousands of years since sea cucumbers became a trad-
itional tonic food in China and their medical value has
already been acknowledged widely [28]. A. molpadioides,
material of SC-PC used in this study, is low-value and
high yielding with an extensive distribution around the
coastal regions of China [29]. Squid (Sthenoteuthis ouala-
niensis) roe, used to extract SQ-PC, is the wastes of pro-
cessing and so that it is a kind of deep processing to
extract phospholipid from this byproduct [30]. Here we
investigated three different kinds of phosphatidylcholine
(PC) respectively from egg yolk, squid roe and sea cucum-
ber and comparatively studied the effects of different fatty
acid composition of PC on brain function. Scopolamine, a
traditional anti-cholinergic drugs, is reported to have the
capability of impairing spatial learning and memory and
influencing the formation of short term memory [31]. In
addition, 7 days of SCO-administration has been found to
elevate oxidative stress level in rat brain and also increased
the neuroinflammatory in the hippocamous [32].
In water maze test, the result of latency showed that egg
yolk lecithin (EL), squid PC (SQ-PC) and sea cucumber
PC (SC-PC) all can prevent the damage of SCO-
administration in mice brain. Otherwise, SQ-PC and SC-
PC performed better than EL. Numbers of crossing the
platform and time in the target quadrant was used to
measure the short term memory of mice. Results revealed
that PC improved the decline of memory and in consist-
ent with the place navigation test, SQ-PC and SC-PC with
massive n-3 PUFA have more effective functions. Accord-
ing to the behavior test, SQ-PC rich in DHA and SC-PC
rich in EPA have a better protection of brain from being
damaged in spatial learning and memory by SCO-
administration than EL (which barely contained EPA or
DHA). Dietary supplement of PC helps slow the aging
process and enhance intelligence [33, 34]. As one of the
main cerebral material and possessed a high ratio in cere-
bral fat, it is widely accepted that DHA plays a vital part
on maintaining the fluency of cytomembrane and has a re-
lationship with the transmission of nerve signals [34, 35].
The enhanced function of cytomembrane produces ameli-
oration of cell information conducting and leads to raise
the activity of brain and nervous system. Recent studied
has demonstrated that dietary intake of EPA can be con-
verted into DHA rapidly in brain [35]. EPA and DHA
probably adopt some common pathways to prevent cogni-
tive decline. Thus, different fatty composition of PC
molecule showed different degree of improvement on be-
havior test and the species that contained abundant DHA
or EPA acted even better.
Ach, a major neurotransmitter in the central cholinergic
system, is known to be closely associated with learning
and memory. AchE, the hydrolase of Ach, is investigated
to evaluate the influence on nerve conduction [36]. There
Fig. 4 Comparison of MAO activity in white matter. Results are
expressed as mean ± SEM; n= 8 mice per group. ##P < 0.01, significant
difference compared with Con group, *P < 0.05, **P < 0.01, significant
difference compared with M group, determined by student’s t test.
Different letters represent significant difference at P < 0.05 among PC
groups determined by ANOVA (Tukey’s test)
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are G1 and G4 isoforms of the enzyme in the brain, both
of which were abundant in different brain areas [37]. It
has been reported that the G1 isoform of AChE was ob-
served in the brain of AD patients [38]. Several studies
suggest that human AChE promotes the fibrilization and
deposition of Aβ in pathological aggregates [39, 40]. De-
crease of choline acetyltransferase (ChAT) activity, in-
crease of acetylcholin esterase (AchE) activity, low acetyl
choline (Ach) content and dysfunction of central nerve
system are important pathologies of AD patients [41]. As
the result shown, the PC groups displayed significance of
reducing the AchE activity in hippocampus, cortex and
white matter. Choline, obtained from PC, combines with
acetyl-CoA and generates Ach in brain tissues. Supple-
mental PC in diet could rise the content of choline in
brain, and the shrinkage of AchE suppressed the decom-
position of Ach, then increased the level of Ach and
gained a better effect on cognitive behavior. In addition, it
has been reported that n-3 PUFA may have an influence
on signal recognition and transduction which was related
to the transmission of cholinergic pathways [42]. Accord-
ing to our data, the depression of AchE activity in hippo-
campus, cortex and white matter was executed better by
PC which had high n-3 PUFA content in fatty acids than
that with EPA or DHA scarcely included.
Oxidative stress has been one of the primary factors
of cognitive decline in neurodegenerative disease for
many years. Superoxide anion radicals is the inevit-
able by-product of the mitochondrial respiration [43].
On the basis of free-radical theory, the reactive oxy-
gen species (ROS) induce the oxidative stress, leading
to the damage of protein and DNA, lipid peroxidation
and the toxicity against mitochondrial structures. It is
so susceptible to oxidation for the long polyunsatur-
ated fatty acid chains of mitochondrial membranes
that may lead to the depolarization of membrane and
consecutively to mitochondrial impairments [44, 45].
SOD, a momentous antioxidative enzyme, is able to
prevent the free radicals from disrupting cells by
translating superoxide radical into hydrogen peroxide
[46]. As a molecule of cytotoxicity, MDA indicates
the degree of membrane lipid peroxidation. The mice
with intake of PC acquired better amelioration of oxi-
dative stress (Fig. 3). Interestingly, we found that PC
with a mass of DHA was more effective than that
with abundant EPA on enhancing the SOD activity in
hippocampus and the situation was reverse in cortex.
Because of containing EPA and DHA, it was reason-
able and turned out that PC with the composition of
n-3 PUFA gained more powerful strength of antioxi-
dation than ordinary forms [47]. Nonetheless, there is
rarely reported that the distinction of the oxidative
function between DHA and EPA is significant in
specific tissues and moreover, depending on the result
we obtained, the tendency of significance in hippo-
campus was not as same as that in cortex. There are
probably potential mechanisms on the novel
phenomenon we can hardly express now. More inves-
tigation should be developed to demonstrate the
mechanisms. Generally, n-3 PUFA in PC notablely
strengthened the anti-oxidative function on the basis
of the better performance acted by SQ-PC and SC-PC
which were rich in DHA and EPA separately.
MAO, the main enzyme involved in the metabolism
of amine such as serotonin, monoamine and catechol-
amine, has two subunits, MAO-A and MAO-B. Both
forms are found with high level in the brain [48].
MAO-B which is the major form in serotonergic neu-
rons and astrocytes has been discovered to closely re-
late to the impairment of neural functions in central
nervous system [49]. The hydrogen peroxide, gener-
ated by the reactions of MAO and neural transmitter,
could combine with Fe2+ and then free radicals were
created which promotes the damage of neurone [50].
An increase of MAO activity were detected in the
brains of patients with AD [51]. MAO has the ability
of increasing the expression of β-secretase and γ-
secretase and improving Aβ generation [51] and could
be also related to the formation of neurofibrillary tan-
gles [52] when be activated. The alteration of MAO
activity in white matter indicated that the supplemen-
tal PC had effectively decreased the neural lesions. It
is recently reported that 4-weeks’ intragastric admin-
istration of fish oil can significantly decline the 5-
hydroxyindole acetic acid content and MAO activity
and increase serotonin level [53]. In consistent with
the present study, SC-PC and SQ-PC, both rich in n-
3 PUFA, performed better than EL which mainly had
no EPA or DHA on reversing the high MAO activity
induced by SCO-administration.
In summary, intraperitoneal injection of scopolamine
hydrobromide impaired the brain function seriously in
mice and intake of PC could improve the damage effect-
ively. It is widely known that dietary supplement of
phospholipid can facilitate the growth and development
of infant brain [54]. Intragastric administration of DHA-
PC liposome increase the content of unsaturated fatty
acid and depressed the TchE activity in mice brain which
was accordant in this study [55]. Soybean lecithin and
egg yolk lecithin had been reported to improve the
PUFA (especially AA and DHA) content and reduce the
saturated fatty acid content in rat brain by dietary intake
[56]. Boudrault et.al had proved that DHA played a good
effect on preventing dementia in four kinds of AD
mouse models [57]. Fish oil rich in DHA and EPA was
discovered to be capable to decrease anger and anxiety
and had been used as hygienical product of brain health
for several years [58].
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Conclusions
Different fatty acids composition of PC all could dimin-
ish the cognitive decline and biological damage and pro-
tect the brain. As PC rich in EPA or DHA showed better
improvement than that barely contained, n-3 PUFA
partly contributed to the advantageous effects of PC on




The preparation of Squid (Sthenoteuthis oualaniensis,
provided by Weihai Boyu Food Company, Shandong
Province, China) PC and sea cucumber (A. molpa-
dioides, obtained from Nanshan Aquatic Products
Market, Shandong Province, China) PC referenced to
the Folch Method. Dried powder of squid roes and sea
cucumber was extracted with 20-fold volume of the so-
lution of CHCl3/MeOH (2:1) for 24 h respectively. Then
the resultant filtrate was combined with the 0.88 %
(mass fraction) KCl solution into an aqueous condition.
The chloroform layer was collected after stratification
and used to obtain total lipids by vacuum concentration.
Insoluble part of total lipid was dissolved in chloroform
at the end of two times of acetone washing. The solution
was finally separated on a silica-gel column chromatog-
raphy to acquire PC component. The purity of PC ex-
tracted from squid roe and sea cucumber determined
respectively by high performance liquid chromatography
(Waters 2695, Milford, MA) were all greater than 95 %.
Egg yolk lecithin (EL), obtained from Beijing Aobox Bio-
technology co., LTD (Beijing, China), was washed with
cold acetone for three times before utilization. Accord-
ing to the fatty acids composition of EL, SQ-PC and SC-
PC (Table 1), there was barely DHA and EPA in EL and
the content of DHA and EPA were significantly different
between SQ-PC and SC-PC. Scopolamine hydrobromide
were supplied by Shanghai Harvest Pharmaceutical co.,
LTD (Shanghai, China). The kits used in the experiments
were purchased from Nanjing Jiancheng Bioengineering
Institute (Jiangsu Province, China).
Animals and diets
Male BALB/c mice (20 ± 2 g, procured from Beijing Vital
River Experiment Animal Technology co., LTD.) were
housed under temperature (20 ± 2 °C) and relative hu-
midity (50–60 %) with a 12/12 h light/dark cycle (light
starting at 8 a.m.).After 1-week adaptation, mice were
randomly divided into 5 groups (8 animals per group):
model (M) group, control (Con) group, egg yolk lecithin
(EL) group, squid PC (SQ-PC) group and sea cucumber
PC (SC-PC) group. A modified 93-G Diet was used to
feed the mice of Con group and M group. Mice in PC
groups were respectively fed with modified 93 M + 0.5 %
EL (m/m) diet, modified 93 M + 0.5 % SQ-PC diet and
modified 93 M + 0.5 % SC-PC diet. Experimental diets
were prepared in accord with recommendations of the
American Institute of Nutrition. The ingredients of the
experimental diets was displayed in Table 2.
Mice model
The schedule of animal experiments is shown in
Fig. 5. The intraperitoneal injection of scopolamine
hydrobromide (5 mg/kg) of all mice except Con
group initiated on the 8th day of grouped feeding,
Table 1 Main fatty acid composition of EL, SQ-PC and SC-PC
FA composition (%) EL SQ-PC SC-PC
Plamitic acid (C16:0) 29.33 27.46 29.28
Plamitoleic acid (C16:1) 1.68 0.54 0.18
Stearic acid (C18:0) 22.2 15.56 14.36
Oleic acid (C18:1) 24.0 1.37 1.64
Lenoleic acid (C18:2) 14.2 – 0.37
EPA (C22:5) 0.32 11.62 38.39
DHA (C22:6) 1.55 35.28 7.35
Other fatty acids 6.75 8.17 8.43
–, none detected, EPA eicosapentaenoic acid, DHA docosahexaenoic acid
Table 2 ingredients of the experimental dietsa
Ingredients(g kg−1) Con M EL SQ-PC SC-PC
Casein 200 200 200 200 200
Potato starch 500 500 500 500 500
Sucrose 130 130 130 130 130
Corn oil 70 70 65 65 65
Powdered celluose 50 50 50 50 50
Mineral mix 35 35 35 35 35
Vitamin mix 10 10 10 10 10
Choline bitartrate 2.5 2.5 2.5 2.5 2.5
DL-Methionine 3 3 3 3 3
EL – – 5 – –
SQ-PC – – – 5 –
SC-PC – – – – 5
–, none added, EL egg yolk lecithin, SQ-PC squid PC, SC-PC sea
cucumber phosphatidylcholine
aprepared according to AIN-93M
Fig. 5 Experemental design and schedule of animal tests. WMW:
Morris water maze
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while Con group mice were injected with the same
volume of saline. The injection was daily sustained
until the end of test and water maze test started at
1 h after SCO administration.
Behavior test
Morris Water Maze was made up of a trajectory re-
cording device and a circular pool with a platform.
The pool (1.3 m in diameter and 0.5 m in height)
was divided into four quadrants and named respect-
ively: I, III, II, IV. With the water (0.3 m in depth)
temperature controlled at 21–23 °C, the platform
(9 cm in diameter) was submerged 1.5 cm under the
water level in the center of quadrant I. A camera
linked to a computer was located 2 m above the cen-
ter of the pool and the movement of the mice trajec-
tory was automatically recorded and analyzed by
ANY-maze behavior tracking software (Stoelting Co.,
Wood Dale, USA). The test included place navigation
test and spatial probe test. In place navigation test,
each mouse received four trails to be trained to find
the platform when being put into the pool respect-
ively from four different quadrants and the sequence
was changed every day during the whole training.
The time of finding the platform was recorded as la-
tency. If the animal was unable to arrive the hidden
platform within 60s test, the latency was recorded as
60s and mouse was placed on the platform for 10s by
hand. There was a 20s interval between each trail.
The spatial probe test was carried out on the 7th day
while the platform was removed and the animals were
placed into the pool from quadrant III (opposite to
quadrant I) and allowed to search the whole area
until the termination. Swim path, time in target quad-
rant (quadrant I) and numbers of crossing the plat-
form were measured and analyzed.
Tissues and biological test
One day after the behavior test, mice were sacrificed
and their brains were rapidly separated and divided
into cortex, hippocampus and white matter. The in-
tact brain tissue was dissected into left and right
brain after cerebellum was removed. With the hemi-
sphere being unfolded from the gap of ventricle, the
Crescent-shaped hippocampus was drawn out gently.
The metathalamus under the gap should be infibu-
lated so that the lamellar white matter attached above
the ventricle could be avulsed lightly. The part con-
nected to the white matter was discard to ensure the
purity of the cortex.
Brain tissues were respectively extracted with saline
at the mass-liquid ratio of 1:9, then the tissue hom-
ogenate was centrifuged at 3500 r/min for 10 min.
The supernate fluid was applied to measure enzymes
activity through the related kits including Acetyl-
cholinesterase (AchE) and superoxide dismutase
(SOD) activity in cortex, white matter and hippocam-
pus, monoamine oxidase (MAO) in white matter and
malondialdehyde (MDA) content of right brain.
Statistical analysis
All experiment data were analyzed by SPSS 19.0 and
presented as means ± standard errors. Student’s t test
was used to determine the difference between Con
group and M group as well as that between the PC
groups and M group, the difference between the PC
groups were evaluated by One-way ANOVA with
Tukey’s post hoc test. Differences were considered sig-
nificant at P < 0.05.
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